Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Glomerulonephritis

• Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous Nephropathy
• Study of BHV-1400 in IgA Nephropathy
• Atacicept in Multiple Glomerular Diseases
• The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland
• Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
• Effect of Finerenone in Patients With Non-diabetic Glomerulonephritis
• Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-prov
• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
• NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1)
• KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
• Rescue of Nephrons With ALE.F02 (RENAL-F02)
• An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
• Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits
• A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients
• Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis
• Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
• Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency
• Bortezomib for Treating Glomerular Diseases
• Empagliflozin in Patients With Glomerulonephritis
• Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
• An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
• Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE)
• A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy
• Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.
• Efficacy of Corticosteroids in Reducing the Renal Scarring in Acute Pyelonephritis in Children
• Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN
• A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease
• Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis
• Huaiqihuang Granule in CKD Stage 3 Primary Glomerulonephritis
• Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
• Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
• Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)
• Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
• Mesenchymal Stromal Cells (MSC´s) in Renal Lupus
• A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)
• Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted
• A Proof of Concept Study for a 12 Month Treatment in Patients With C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
• Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
• A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)
• Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
• Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis
• A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN
• Daratumumab in Treatment of PGNMID and C3 GN
• Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy
• ACE-inhibitors in Extracapillary Glomerulonephritis
• Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
• Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
• Efficacy and Safety of Losartan in Children With Ig A Nephropathy
• Pilot Study of Rituximab to Treat Fibrillary Glomerulonephritis
• A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.
• Eculizumab in Primary MPGN
• Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis
• ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
• Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
• Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy
• A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
• Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)
• Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy
• Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
• A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy
• Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
• Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis
• A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy
• The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy
• Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
• Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy
• Calcitriol in the Treatment of Immunoglobulin A Nephropathy
• Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis
• Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
• Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant
• Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor
• A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
• HSP-glomerulonephritis Trial: MP vs CyA
• Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
• A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis
• Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy
• ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT
• Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis
• Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic Glomerulonephritis
• Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
• Evaluation of Clinical Efficacy of Pentoxifylline on Patients With Glomerulonephritis
• Mycophenolate Mofetil in Membranous Nephropathy
• Treatment of Patients With Idiopathic Membranous Nephropathy
• Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
• Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
• Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease
• Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy
• Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis
• Alternate Day Prednisone or Daily Fish Oil Supplements in Patients With Immunoglobulin A Nephropathy
• BG9588 (Anti-CD40L Antibody) to Treat Lupus Nephritis
• Cyclophosphamide and Fludarabine to Treat Lupus Nephritis
• Lamivudine for Chronic Hepatitis B